Market News / Story
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
GlobeNewswire ·
GlobeNewswire reports: Southlake, TX, Oct. 06, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that the U.S. Food and Drug Administration (“FDA”) has granted 510(k) clearance (K260005) for its MyoVista® wav ECGTM device as a 12-lead resting…